[Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001262:Atenolol / Q000494:pharmacology; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000503:physiopathology*; D004195:Disease Models, Animal; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography / Q000379:methods; D004699:Endocardium / Q000187:drug effects; D008863:Microspheres; D010496:Pericardium / Q000187:drug effects; D010869:Pindolol / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011851:Radioactivity
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D011433:Propranolol; D010869:Pindolol; D011217:Practolol
Bêta-bloquants: redistribution du débit sanguin coronaire et ischémie myocardique expérimentale.